1. SAT0575 Safety and efficacy of lutikizumab (ABT-981), an anti–interleukin-1 alpha/beta dual variable domain (DVD) immunoglobulin, in subjects with knee osteoarthritis: results from the randomised, double-blind, placebo-controlled, parallel-group phase 2 trial. (12th June 2018) Authors: Fleischmann, R.; Bliddal, H.; Blanco, F.; Schnitzer, T.; Peterfy, C.; Chen, S.; Wang, L.; Conaghan, P.; Berenbaum, F.; Pelletier, J.-P.; Martel-Pelletier, J.; Vaeterlein, O.; Liu, W.; Levy, G.; Zhang, L.; Medema, J.; Levesque, M. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗